ezetimibe has been researched along with Chronic Illness in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fras, Z; Mikhailidis, DP | 1 |
Arrese, M; Bizama, C; Espinoza, JA; Ferreccio, C; García, P; Gómez, N; González, X; Guevara, F; Kalergis, AM; Lobos-González, L; Miquel, JF; Muñoz-Durango, N; Roa, JC; Rosa, L; Saavedra, N; Villegas, J; Wichmann, IA | 1 |
Cordy, P; Garg, AX; Gomes, T; Hackam, DG; Juurlink, DN; Mamdani, M; Manno, M; Moist, L; Parikh, CR; Paterson, JM; Wald, R; Weir, MA; Yao, Z; Zhao, YY | 1 |
Adu, D; Altmann, P; Armitage, J; Baigent, C; Ball, S; Baxter, A; Blackwell, L; Cairns, HS; Carr, S; Collins, R; Kourellias, K; Landray, M; Leaper, C; Rogerson, M; Scoble, JE; Tomson, CR; Warwick, G; Wheeler, DC | 1 |
2 trial(s) available for ezetimibe and Chronic Illness
Article | Year |
---|---|
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease).
Topics: Aged; Anticholesteremic Agents; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Non-alcoholic Fatty Liver Disease; Simvastatin; Treatment Outcome | 2021 |
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.
Topics: Anticholesteremic Agents; Azetidines; Chronic Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Kidney Diseases; Male; Middle Aged; Simvastatin | 2006 |
2 other study(ies) available for ezetimibe and Chronic Illness
Article | Year |
---|---|
Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia.
Topics: Animals; Aspirin; Chemoprevention; Cholecystolithiasis; Cholesterol; Cholesterol, Dietary; Chronic Disease; Diet; Disease Models, Animal; Disease Progression; Ezetimibe; Fatty Liver; Feeding Behavior; Gallbladder Neoplasms; Gallstones; Inflammation; Male; Metaplasia; Mice, Inbred C57BL; Precancerous Conditions; Spleen | 2020 |
New fibrate use and acute renal outcomes in elderly adults: a population-based study.
Topics: Age Factors; Aged; Anticholesteremic Agents; Azetidines; Chronic Disease; Creatinine; Dyslipidemias; Ezetimibe; Female; Fibric Acids; Glomerular Filtration Rate; Hospitalization; Humans; Kidney Diseases; Male; Randomized Controlled Trials as Topic | 2012 |